Valneva’s 2024 Universal Registration Document – available in its entirety in French – includes the Company’s 2024 Annual Financial Report, the Company's Annual Management Report, the Board of ...

Guggenheim analyst Vamil Divan lowered the firm’s price target on Valneva (VALN) to $15 from $17 and keeps a Buy rating on the shares. The ...

Valneva has a 1-year low of $3.62 and a 1-year high of $9.50. The company has a current ratio of 2.78, a quick ratio of 2.25 and a debt-to-equity ratio of 0.70.

If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older Saint Herblain (France), February 28, 2025 - ...

Saint-Herblain (France), March 3, 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) a specialty vaccine company, today announced that its senior management will participate at upcoming investor ...

“Austria’s capacities are limited, and that is why we have decided to prevent further overloading,” Stocker said. The new measure means that migrants with so-called protected status ...

VALNEVA Declaration of shares and voting rights February 28, 2025_____ Company name: VALNEVARegistered office ...

Valneva has bolstered its vaccines pipeline with a shot designed to protect against shigellosis – a major global health threat – licensed from LimmaTech Biologics. The French pharma company ...

New data for Valneva and Pfizer's experimental vaccine for Lyme disease – the furthest ahead in clinical testing – have bolstered the case for the shot as the results of a phase 3 programme ...

Austria's housing market remains gloomy, amidst weak demand and falling residential construction activity, which is aggravated further by the country's ailing economy. The residential property price ...

Chrissy Teigen’s midnight snacks rival the menus of some restaurants. The mogul, model and mother of four appeared on TODAY March 12 to talk about adding another title to her resume: podcast hos ...